留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

眼科远程医疗发展现状与前景

张潇 陈有信

张潇, 陈有信. 眼科远程医疗发展现状与前景[J]. 协和医学杂志, 2021, 12(5): 755-760. doi: 10.12290/xhyxzz.2021-0198
引用本文: 张潇, 陈有信. 眼科远程医疗发展现状与前景[J]. 协和医学杂志, 2021, 12(5): 755-760. doi: 10.12290/xhyxzz.2021-0198
ZHANG Xiao, CHEN Youxin. Current Situation and Prospect of Teleophthalmology[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 755-760. doi: 10.12290/xhyxzz.2021-0198
Citation: ZHANG Xiao, CHEN Youxin. Current Situation and Prospect of Teleophthalmology[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 755-760. doi: 10.12290/xhyxzz.2021-0198

眼科远程医疗发展现状与前景

doi: 10.12290/xhyxzz.2021-0198
基金项目: 

中国医学科学院中央级公益性科研院所基本科研业务费专项基金 2018PT32029

详细信息
    通讯作者:

    陈有信  电话:010-69156351,E-mail:chenyouxinpumch@163.com

  • 中图分类号: R770.4; TP18

Current Situation and Prospect of Teleophthalmology

Funds: 

The Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2018PT32029

More Information
  • 摘要: 随着技术的进步,医生可通过远程医疗进行疾病的诊断和治疗。目前眼科远程医疗主要用于某些眼科疾病的筛查和诊断、慢性眼病的监测,以及眼科疾病的远程会诊等。随着眼科远程医疗的需求及应用不断增加,逐渐暴露出存在的一些问题,如基础设施和人员配备、医疗风险、患者接受度和满意度、网络安全和隐私保护、医疗保险覆盖等。COVID-19疫情全球大流行将远程医疗推向了眼科医疗服务的前沿,并可能持续改变眼科疾病的诊疗模式。随着人工智能技术的发展、5G通信网络覆盖范围的扩大、基层医疗服务人员培训的规范化及相关法律法规的出台,眼科远程医疗将更加规范和完善,应用范围更加广泛,为患者提供高质量、可持续性的医疗服务。
    作者贡献:张潇负责文献检索、资料整理及文章撰写;陈有信负责文章框架设计、总体规划及审核。
    利益冲突:
  • [1] Dorsey ER, Topol EJ. State of Telehealth[J]. N Engl J Med, 2016, 375: 154-161. doi:  10.1056/NEJMra1601705
    [2] Parikh D, Armstrong G, Liou V, et al. Advances in Telemedicine in Ophthalmology[J]. Semin Ophthalmol, 2020, 35: 210-215. doi:  10.1080/08820538.2020.1789675
    [3] Hadziahmetovic M, Nicholas P, Jindal S, et al. Evaluation of a Remote Diagnosis Imaging Model vs Dilated Eye Examination in Referable Macular Degeneration[J]. JAMA Ophthalmol, 2019, 137: 802-808. doi:  10.1001/jamaophthalmol.2019.1203
    [4] Grau E, Horn F, Nixdorff U, et al. OCT and IOP findings in a healthy worker cohort: results from a teleophthalmic study in occupational medicine[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257: 2571-2578. doi:  10.1007/s00417-019-04457-1
    [5] Saeedi P, Petersohn I, Salpea P, et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition[J]. Diabetes Res Clin Pract, 2019, 157: 107843. doi:  10.1016/j.diabres.2019.107843
    [6] Yau JW, Rogers SL, Kawasaki R, et al. Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care, 2012, 35: 556-564. doi:  10.2337/dc11-1909
    [7] Wong TY, Sabanayagam C. Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence[J]. Ophthalmologica, 2020, 243: 9-20. doi:  10.1159/000502387
    [8] Scotland GS, McNamee P, Fleming AD, et al. Scottish Diabetic Retinopathy Clinical Research Network. Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy[J]. Br J Ophthalmol, 2010, 94: 712-719. doi:  10.1136/bjo.2008.151126
    [9] Nguyen HV, Tan GS, Tapp RJ, et al. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore[J]. Ophthalmology, 2016, 123: 2571-2580. doi:  10.1016/j.ophtha.2016.08.021
    [10] Horton MB, Brady CJ, Cavallerano J, et al. Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition[J]. Telemed J E Health, 2020, 26: 495-543. doi:  10.1089/tmj.2020.0006
    [11] Fonda SJ, Bursell SE, Lewis DG, et al. The Indian Health Service Primary Care-Based Teleophthalmology Program for Diabetic Eye Disease Surveillance and Management[J]. Telemed J E Health, 2020, 26: 1466-1474. doi:  10.1089/tmj.2019.0281
    [12] Ting DSW, Cheung CY, Lim G, et al. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes[J]. JAMA, 2017, 318: 2211-2223. doi:  10.1001/jama.2017.18152
    [13] Trese MT. What is the real gold standard for ROP screening?[J]. Retina, 2008, 28: S1-S2. doi:  10.1097/IAE.0b013e31816a5587
    [14] Brady CJ, D'Amico S, Campbell JP. Telemedicine for Retinopathy of Prematurity[J]. Telemed J E Health, 2020, 26: 556-564. doi:  10.1089/tmj.2020.0010
    [15] Shah PK, Ramya A, Narendran V. Telemedicine for ROP[J]. Asia Pac J Ophthalmol (Phila), 2018, 7: 52-55.
    [16] Li JO, Liu H, Ting DSJ, et al. Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective[J]. Prog Retin Eye Res, 2021, 82: 100900. doi:  10.1016/j.preteyeres.2020.100900
    [17] Court JH, Austin MW. Virtual glaucoma clinics: patient acceptance and quality of patient education compared to standard clinics[J]. Clin Ophthalmol, 2015, 9: 745-749. http://www.dovepress.com/virtual-glaucoma-clinics-patient-acceptance-and-quality-of-patient-edu-peer-reviewed-article-OPTH
    [18] Odden JL, Khanna CL, Choo CM, et al. Telemedicine in long-term care of glaucoma patients[J]. J Telemed Telecare, 2020, 26: 92-99. doi:  10.1177/1357633X18797175
    [19] Gan K, Liu Y, Stagg B, et al. Telemedicine for Glaucoma: Guidelines and Recommendations[J]. Telemed J E Health, 2020, 26: 551-555. doi:  10.1089/tmj.2020.0009
    [20] Brady CJ, Garg S. Telemedicine for Age-Related Macular Degeneration[J]. Telemed J E Health, 2020, 26: 565-568. doi:  10.1089/tmj.2020.0011
    [21] Hwang DK, Hsu CC, Chang KJ, et al. Artificial intelligence-based decision-making for age-related macular degeneration[J]. Theranostics, 2019, 9: 232-245. doi:  10.7150/thno.28447
    [22] Li B, Powell AM, Hooper PL, et al. Prospective evalua-tion of teleophthalmology in screening and recurrence monitoring of neovascular age-related macular degeneration: a randomized clinical trial[J]. JAMA Ophthalmol, 2015, 133: 276-282. doi:  10.1001/jamaophthalmol.2014.5014
    [23] Wittenborn JS, Clemons T, Regillo C, et al. Economic Evaluation of a Home-Based Age-Related Macular Degenera-tion Monitoring System[J]. JAMA Ophthalmol, 2017, 135: 452-459. doi:  10.1001/jamaophthalmol.2017.0255
    [24] Acemoglu A, Peretti G, Trimarchi M, et al. Operating From a Distance: Robotic Vocal Cord 5G Telesurgery on a Cadaver[J]. Ann Intern Med, 2020, 173: 940-941. doi:  10.7326/M20-0418
    [25] Sachdeva N, Klopukh M, Clair RS, et al. Using conditional generative adversarial networks to reduce the effects of latency in robotic telesurgery[J]. J Robot Surg, 2021, 15: 635-641. doi:  10.1007/s11701-020-01149-5
    [26] Zheng J, Wang Y, Zhang J, et al. 5G ultra-remote robot-assisted laparoscopic surgery in China[J]. Surg Endosc, 2020, 34: 5172-5180. doi:  10.1007/s00464-020-07823-x
    [27] Chen H, Pan X, Yang J, et al. Application of 5G Technology to Conduct Real-Time Teleretinal Laser Photocoagulation for the Treatment of Diabetic Retinopathy[J]. JAMA Ophthalmol, 2021. doi:  10.1001/jamaophthalmol.2021.2312.
    [28] Annoh R, Patel S, Beck D, et al. Digital ophthalmology in Scotland: benefits to patient care and education[J]. Clin Ophthalmol, 2019, 13: 277-286. doi:  10.2147/OPTH.S185186
    [29] Tatham AJ, Ali AM, Hillier N. Knowledge of Glaucoma Among Patients Attending Virtual and Face-to-Face Glaucoma Clinics[J]. J Glaucoma, 2021, 30: 325-331. doi:  10.1097/IJG.0000000000001758
    [30] Patel AJ, Kloosterboer A, Yannuzzi NA, et al. Evaluation of the Content, Quality, and Readability of Patient Accessible Online Resources Regarding Cataracts[J]. Semin Ophthalmol, 2021, 36: 384-391. doi:  10.1080/08820538.2021.1893758
    [31] Chong JC, Tan CHN, Chen DZ. Teleophthalmology and its evolving role in a COVID-19 pandemic: A scoping review[J]. Ann Acad Med Singap, 2021, 50: 61-76. doi:  10.47102/annals-acadmedsg.2020459
    [32] Faes L, Rosenblatt A, Schwartz R, et al. Overcoming barriers of retinal care delivery during a pandemic-attitudes and drivers for the implementation of digital health: a global expert survey[J]. Br J Ophthalmol, 2020. doi:  10.1136/bjophthalmol-2020-316882.
    [33] Portney DS, Zhu Z, Chen EM, et al. COVID-19 and Use of Teleophthalmology (CUT Group): Trends and Diagnoses[J]. Ophthalmology, 2021. doi:  10.1016/j.ophtha.2021.02.010.
    [34] Bourdon H, Herbaut A, Trinh L, et al. An algorithm in ophthalmic emergencies to evaluate the necessity of physical consultation during COVID-19 lockdown in Paris: Experi-ence of the first 100 patients[J]. J Fr Ophtalmol, 2021, 44: 307-312. doi:  10.1016/j.jfo.2020.12.002
    [35] Ghazala FR, Hamilton R, Giardini ME, et al. Teleophthalmology techniques increase ophthalmic examination distance[J]. Eye(Lond), 2021, 6: 1780-1781. http://www.nature.com/articles/s41433-020-1085-8
    [36] Sommer AC, Blumenthal EZ. Telemedicine in ophthalmology in view of the emerging COVID-19 outbreak[J]. Graefes Arch Clin Exp Ophthalmol, 2020, 258: 2341-2352. doi:  10.1007/s00417-020-04879-2
    [37] Rathi S, Tsui E, Mehta N, et al. The Current State of Teleophthalmology in the United States[J]. Ophthalmology, 2017, 124: 1729-1734. doi:  10.1016/j.ophtha.2017.05.026
    [38] Wildenbos GA, Peute L, Jaspers M. Aging barriers influencing mobile health usability for older adults: A literature based framework (MOLD-US)[J]. Int J Med Inform, 2018, 114: 66-75. doi:  10.1016/j.ijmedinf.2018.03.012
    [39] Gioia G, Salducci M. Medical and legal aspects of telemedicine in ophthalmology[J]. Rom J Ophthalmol, 2019, 63: 197-207. doi:  10.22336/rjo.2019.31
  • 加载中
计量
  • 文章访问数:  27
  • HTML全文浏览量:  5
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-02-17
  • 录用日期:  2021-04-21
  • 网络出版日期:  2021-09-01
  • 刊出日期:  2021-10-12

目录

    /

    返回文章
    返回